블로그
- [Philippines FDA] FDA Advisory No.2026-0622 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0622 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Pepslim Bacteriostatic Water 3mL Vial” Updated: 2026-06-05 The Food and Drug Administration (FDA
- [U.S. FDA] FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Co FDA Advisory No.2026-0612 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug The concerned batch of Equirab has an authentic counterpart available in the market.
- [Philippines FDA] FDA Advisory No.2026-0608 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0608 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Freeze-Dried Powder for Injection (IM/ID)” Updated: 2026-06-02 The Food and Drug Administration (FDA)
- [Philippines FDA] FDA Advisory No.2026-0601 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0601 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Freeze-Dried Powder for Injection (IM/ID)” Updated: 2026-05-28 The Food and Drug Administration (FDA)
- [U.S. FDA] FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, currently required under federal law to register their establishments and list their products with the FDA In contrast, foreign tobacco product manufacturers are not subject to these .......
- [Philippines FDA] FDA Advisory No.2026-0599 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0599 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Ibuprofen (Medicol® Advance) 200 mg Softgel Capsule” Updated: 2026-05-28 The Food and Drug Administration (FDA
- [U.S. FDA] FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone Consumers may directly purchase this product without a prescription in places such as pharmacies, convenience
- [U.S. FDA] FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children The FDA previously cleared the Stelo Glucose Biosensor System OTC for individuals 18 years and older in March 2024.
- 셀트리온 “다중항체 신약, 인비트로서 우수효능 및 내약성 관찰” T-Cell Engager Summit South Korea서 신약 중간 연구결과 발표 HER2 발현 정도에 따른 선택적 항암 효과와 낮은 독성 확인, 담도암 등에서도 효과 연내 美 FDA 예정…‘베스트 인 클래스’ 신약 개발 속도 “내약성·치료지수 토대로 적응증 확장 모색” 셀트리온이 차세대 다중항체 신약으로 개발 중인 ‘CT-P72/ABP-102’의 시험관 내(In
- [U.S. FDA] FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene information, to streamline regulatory submissions for human gene therapy products that use genome editing in